AU2159300A - Combinations of st. john's wort and fatty acids - Google Patents

Combinations of st. john's wort and fatty acids

Info

Publication number
AU2159300A
AU2159300A AU21593/00A AU2159300A AU2159300A AU 2159300 A AU2159300 A AU 2159300A AU 21593/00 A AU21593/00 A AU 21593/00A AU 2159300 A AU2159300 A AU 2159300A AU 2159300 A AU2159300 A AU 2159300A
Authority
AU
Australia
Prior art keywords
wort
john
combinations
fatty acids
fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21593/00A
Inventor
M. D. Timothy Herlihy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutramax Laboratories Inc
Original Assignee
Nutramax Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutramax Laboratories Inc filed Critical Nutramax Laboratories Inc
Publication of AU2159300A publication Critical patent/AU2159300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
AU21593/00A 1998-12-08 1999-11-30 Combinations of st. john's wort and fatty acids Abandoned AU2159300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11161998P 1998-12-08 1998-12-08
US60111619 1998-12-08
PCT/US1999/028186 WO2000033831A1 (en) 1998-12-08 1999-11-30 Combinations of st. john's wort and fatty acids

Publications (1)

Publication Number Publication Date
AU2159300A true AU2159300A (en) 2000-06-26

Family

ID=22339514

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21593/00A Abandoned AU2159300A (en) 1998-12-08 1999-11-30 Combinations of st. john's wort and fatty acids

Country Status (2)

Country Link
AU (1) AU2159300A (en)
WO (1) WO2000033831A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1634595E (en) 2004-08-19 2008-08-28 Rottapharm Spa N-phenylbenzamide derivatives as drugs for the treatment of chronic obstructive pulmonary disease (copd)
FR2908997B1 (en) * 2005-11-25 2014-03-14 R Et D Pharma NEW THERAPEUTIC COMPOSITIONS AND PROCESS FOR PRODUCING THE ACTIVE INGREDIENTS
FR2908996A1 (en) * 2005-11-25 2008-05-30 R & D Pharma NOVEL METHOD OF EXTRACTING ACTIVE INGREDIENTS AND THERAPEUTIC USE THEREOF

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898891A (en) * 1987-08-07 1990-02-06 Yeda Research And Development Company Ltd. Antiviral compositions
RU2106874C1 (en) * 1995-02-01 1998-03-20 Николай Николаевич Бобров-Егоров Phytaon-2,2: biologically active composition and method for its preparing
WO1999037155A1 (en) * 1998-01-27 1999-07-29 Nutramax Laboratories, Inc. Combinations of tyrosine, methylating agents, phospholipids, fatty acids, and st. john's wort for the treatment of mental disturbances

Also Published As

Publication number Publication date
WO2000033831A1 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
AU2470299A (en) Combinations of tyrosine, methylating agents, phospholipids, fatty acids, and st. john's wort for the treatment of mental disturbances
AU4124997A (en) Fatty acid treatment
AU7442398A (en) Glucosamine fatty acid compositions and their use
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
AU3641597A (en) Methods and compositions comprising r-ibuprofen
AU8740398A (en) Amplification of nucleic acids
AU5966198A (en) Amelioration of Dupuytren's disease
AUPN741696A0 (en) Delivery of nucleic acids ii
AU2218497A (en) Aqueous fluoropolymer compositions and method of preparing the same
AU2646497A (en) Amplification of nucleic acids
AU5836498A (en) N-acyl-hydroxyamino acid esters and their use
AU4834200A (en) Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof
ZA979295B (en) Methods and compositions for delivery and expression of interferon-Ó nucleic acids.
AU2969597A (en) Treatment of vascular lesions
AU3176595A (en) Fatty acid treatment
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU2159300A (en) Combinations of st. john's wort and fatty acids
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU1295099A (en) Water repellent restorative and process of use
AU2381597A (en) Alkaline lipase and detergent composition active at low temperature
AU1856297A (en) Lyst1 and lyst2 gene compositions and methods of use
AU9293298A (en) Functionalized polymeric hydroxy fatty acids and methods of making and using thesame
AU2622397A (en) Fluoroalkylglycosiduronic acids and corresponding 6(3)-lactones, preparation and uses
AU8580598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6786798A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase